|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
|
||||
|
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
|
GlaxoSmithKline Plc
|
|||
|
2. Reason for the notification (please tick the appropriate box or boxes):
|
||||
|
An acquisition or disposal of voting rights
|
Yes
|
|||
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.
|
||||
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
|
||||
|
An event changing the breakdown of voting rights
|
||||
|
Other (please specify):
|
||||
|
3. Full name of person(s) subject to the
notification obligation:
|
||||
|
4. Full name of shareholder(s)
(if different from 3.):
|
N/A
|
|||
|
5. Date of the transaction and date on
which the threshold is crossed or
reached:
|
09 July 2013
|
|||
|
6. Date on which issuer notified:
|
10 July 2013
|
|||
|
7. Threshold(s) that is/are crossed or
reached:
|
L&G (Below 3%)
|
|||
|
8. Notified details:
|
||||||||||||||||
|
A: Voting rights attached to shares
|
||||||||||||||||
|
Class/type of
shares
if possible using
the ISIN CODE
|
Situation previous
to the triggering
transaction
|
Resulting situation after the triggering transaction
|
||||||||||||||
|
Number
of
Shares
|
Number
of
Voting
Rights
|
Number
of shares
|
Number of voting
rights
|
% of voting rights
|
||||||||||||
|
Direct
|
Indirect
|
Direct
|
Indirect
|
|||||||||||||
|
Ordinary 25p
|
207,246,143
(As on 17/08/2010)
|
Below 3%
|
||||||||||||||
|
B: Qualifying Financial Instruments
|
||||||||||||||||
|
Resulting situation after the triggering transaction
|
||||||||||||||||
|
Type of financial
instrument
|
Expiration
date
|
Exercise/
Conversion Period
|
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
|
% of voting
rights
|
||||||||||||
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
|
||||||||||||||||
|
Resulting situation after the triggering transaction
|
||||||||||||||||
|
Type of financial
instrument
|
Exercise price
|
Expiration date
|
Exercise/
Conversion period
|
Number of voting rights instrument refers to
|
% of voting rights
|
|||||||||||
|
Nominal
|
Delta
|
|||||||||||||||
|
Total (A+B+C)
|
||||||||||||||||
|
Number of voting rights
|
Percentage of voting rights
|
|||||||||||||||
|
Below 3%
|
||||||||||||||||
|
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
|
|
|
Legal & General Group Plc (Direct and Indirect) (Group)
|
|
|
Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect)
|
|
|
Legal & General Investment Management Limited (Indirect) (LGIM)
|
|
|
Legal & General Group Plc (Direct) (L&G) ( Below 3% = LGAS, LGPL & PMC)
|
|
|
Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD)
|
Legal & General Insurance Holdings Limited (Direct) (LGIH)
|
|
Legal & General Assurance (Pensions Management) Limited (PMC)
|
Legal & General Assurance Society Limited (LGAS & LGPL)
|
|
Legal & General Pensions Limited (Direct) (LGPL)
|
|
| Proxy Voting: | |
|
10. Name of the proxy holder:
|
N/A |
|
11. Number of voting rights proxy holder will cease
to hold:
|
N/A
|
|
12. Date on which proxy holder will cease to hold
voting rights:
|
N/A
|
| 13. Additional information: | Notification using the total voting rights figure of 4,909,366,589 |
|
14. Contact name:
|
Angela Hayter (LGIM)
|
|
15. Contact telephone number:
|
020 3124 3851
|